CON (Concentra Group Holdings Parent) Research & Development: $0 Mil (TTM As of Mar. 2026)


CON Concentra Group Holdings Parent Inc CON
19 GF Score
Price $29.14
! 7 Warning Signs
View Full Analysis

What is Concentra Group Holdings Parent Research & Development?

Concentra Group Holdings Parent CON +1.67% 19 Research & Development is $0 Mil as of Mar. 2026. GuruFocus rates CON with a GF Score™ of 19/100. The stock has 7 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Concentra Group Holdings Parent's Research & Development for the three months ended in Mar. 2026 was $0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was $0 Mil.


Concentra Group Holdings Parent  (NYSE:CON) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Concentra Group Holdings Parent Research & Development Related Terms


Concentra Group Holdings Parent Research & Development Historical Data

* Premium members only.

The historical data trend for Concentra Group Holdings Parent's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Concentra Group Holdings Parent Research & Development Chart

Concentra Group Holdings Parent Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
0.00 0.00 0.00 0.00 0.00

Concentra Group Holdings Parent Quarterly Data
Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
CON
19GF Score
Concentra Group Holdings Parent Inc CON
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Concentra Group Holdings Parent Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0 Mil mean?
Concentra Group Holdings Parent (CON) has a Research & Development of $0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Concentra Group Holdings Parent and its competitors.
Is Concentra Group Holdings Parent's Research & Development too high?
Concentra Group Holdings Parent's current Research & Development is $0 Mil. Overall, Concentra Group Holdings Parent has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Concentra Group Holdings Parent's Research & Development compare to OPCH and BKD?
Concentra Group Holdings Parent's Research & Development of $0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Concentra Group Holdings Parent and its competitors. Concentra Group Holdings Parent's current Research & Development is $0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Concentra Group Holdings Parent stock overvalued right now?
Concentra Group Holdings Parent (CON) has a current Research & Development of $0 Mil. The current Research & Development is $0 Mil. Concentra Group Holdings Parent's overall GF Score™ is 19/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Concentra Group Holdings Parent (CON), the current Research & Development is $0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Concentra Group Holdings Parent Business Description

Address 5080 Spectrum Drive, Suite 1200W, Addison, TX, USA, 75001
Concentra Group Holdings Parent Inc is a provider of occupational health services in the USA. The business is organized into three operating segments: occupational health centers, onsite health clinics, and other businesses.
19GF Score

Get the complete analysis for CON

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$29.14
Price